Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05440422
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2022-06-29
Brief Title:
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus SLE - IFN-CVD
Sponsor:
National Institute of Arthritis and Musculoskeletal and Skin Diseases NIAMS
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-29
First Submit QC Date:
June 29 2022
Study First Post Date:
2022-06-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-07
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL